Tang Capital
View Older Stories View More Recent Stories
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Jun 30
-
Form SC 13G HilleVax, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G AGILE THERAPEUTICS INC Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31
-
Form SC 13G MARINUS PHARMACEUTICALS, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Outlook Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 TCR2 THERAPEUTICS INC. For: Jun 01 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A InflaRx N.V. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A KalVista Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A ANAPTYSBIO, INC Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Adicet Bio, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Pyxis Oncology, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A bluebird bio, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Transcode Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A TCR2 THERAPEUTICS INC. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Quince Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Kinnate Biopharma Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Aclaris Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Aligos Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Altimmune, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A AVROBIO, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Genfit S.A. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Tonix Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A BIONOMICS LIMITED/FI Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Bellerophon Therapeutics Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SC 13G/A Evolus, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A REVIVA PHARMACEUTICALS Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Tharimmune, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Tarsus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A BioAtla, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A MEI Pharma, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Elevation Oncology, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Graphite Bio, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G PRECISION BIOSCIENCES Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Rain Oncology Inc. For: Jan 26 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Rain Oncology Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Ventyx Biosciences, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Corbus Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A ASLAN Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D Reneo Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Theseus Pharmaceuticals (THRX) Acquired by Concentra Biosciences for $3.90-$4.05/sh Cash Plus CVR
-
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
-
Form 4 Rain Oncology Inc. For: Dec 14 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Tharimmune, Inc. Filed by: TANG CAPITAL PARTNERS LP


